*Klebsiella pneumoniae* (*Enterobacteriaceae*) is an opportunist human pathogen that accounts for a significant proportion of hospital-acquired urinary tract infections, pneumonia, septicaemia, and soft tissue infections. Due to its ability to spread rapidly in a hospital environment and resistance to multiple drugs, this strain is for nosocomial outbreaks world-wide, generally associated with high morbidity and mortality ([@b5],[@b6]).

One of the most prevalent mechanisms of bacterial resistance among Gram-negative bacteria is the production of β-lactamases. Extended-spectrum β-lactamases (ESBLs) are a group of clinically very important β-lactamases because they are able to hydrolyze the extended-spectrum cephalosporins (ceftazidime, cefotaxime, ceftriaxone) and monobactans (aztreonam) ([@b2]). Frequently, bacterial species will not only possess a β-lactamase, but also exhibit porin deletion and thus resistance derives from a synergy between reduced permeability and β-lactamase activity ([@b8]). The outer-membrane proteins (OMPs) of *Enterobacteriaceae* have medical importance because its constituents play major roles in the permeability of antimicrobial agents and substrates, and in interactions with the host defense mechanisms ([@b3]).

The aim of the present study was to evaluate the relationship between the resistances of ESBL-expressing *K. pneumoniae* clinical isolates and lost outer membrane proteins.

The *K. pneumoniae* isolates were collected from hospitalized patients in the Walter Cantídio University Hospital, Fortaleza/Brazil, in June of 2005. The strains were identified by standard biochemical methods and *K. pneumoniae* ATCC 4352 and *E.coli* ATCC 25922 was used as the reference strain. The strains were maintained as frozen stocks at -70°C in the presence of 15% of glycerol and cultured in brain heart infusion (BHI) agar (Difco) for 24 hours at 37°C for later analysis. Antimicrobial susceptibility to cephalotin, cefoxitin, ceftriaxone, cefotaxime, amoxillin/clavulanate cefepime and aztreonam was performed by disk diffusion method according to Clinical and Laboraty Standards Institute (CLSI) recommendations ([@b7]). All tests were carried out three times. The isolates were further examined by the double-disk synergy test for ESBLs detection as previously described by Vercauteren *et al.* ([@b9]), based on the inhibition toward the disk containing the β-lactamase inhibitor clavulanate.

Electrophoretic analysis of *K. pneumoniae* OMPs was carried out using the buffer system of Laemmli ([@b4]). Bacterial cultures were grown at 37° C overnight in BHI agar medium. The cells were collected by centrifugation (13000g for 3 min.) of 1 mL of culture and suspended in 100 µl of sample buffer. The cells suspensions were boiled at 100°C for 10 minutes. In addition, 20 µl of the protein were used for SDS-PAGE on a vertical slab gel, containing 4% stacking gel and a 17% separating gel. Protein bands were visualized by Coomassie brilliant blue staining. Molecular weights were estimated by comparison with the protein molecular weight markers MW-SDS-70L (Sigma-Aldrich Co., USA), ranging in size from 14,4--94,0 kDa. The protein concentration of bacterial suspension was determined by the Bradford essay ([@b1]).

[Table 1](#tbl1){ref-type="table"} displays the results of antimicrobial susceptibility of *K. pneumoniae* isolates. Kp 3, Kp 6 and Kp 8 were resistant to third and fourth generation cephalosporins and monobactans. Application of the double-disk synergy test procedure also showed that these isolate ESBL production. This data confirmed the observation of Lopes et al., ([@b5]) that *K. pneumoniae* is resistant to a number of antibiotics, mainly extended-spectrum cephalosporins and penicillins, due to acquisition of plasmids that encode for the production of extended-spectrum β-lactamases.

###### 

Antimicrobial susceptibility of *K. pneumoniae* clinical isolates and reference strain

  Strains                  Resistance phenotypes
  ------------------------ ---------------------------------------
  *E. coli* (ATCC 25922)   [-](#tf1-1){ref-type="table-fn"}
  Kp (ATCC 4352)           [-](#tf1-1){ref-type="table-fn"}
  Kp 8                     KF, CRO, ATM, AMC/CAC, CTX,
  Kp 6                     KF, CRO, FOX, ATM, FEP
  Kp 3                     KF, CRO, FOX, ATM, FEP, AMC/CAC, CTX,

not resistance; KF-cephalotin, FOX-cefoxitin, CRO-ceftriaxone, CTX-cefotaxime, FEP-cefepime, ATM-aztreonam, AMC/CAC-amoxicilin/clavulanate.

SDS-PAGE analysis ([Fig. 1](#fig1){ref-type="fig"}) of the *K. pneumoniae* isolates revealed several proteins bands in the 30 to 66 kDa range. The results of this study indicate that Kp3, Kp 6 and Kp 8 strains, resistant to aztreonam and all cephalosporins ([Table 1](#tbl1){ref-type="table"}) to loss one porin. However, we can say that this porin is 30--43 kDa range, suggesting that it may be OmpK35 or OmpK36. It has been clearly demonstrated that porin deficiency contributes to increasing the level of resistance to ESBLs-producing strains ([@b3]).

![SDS-PAGE analysis of *Klebsiella pneumoniae* clinical isolates. Molecular sizes (lane 1), *E. coli* ATCC 25922 (lane 2), Kp ATCC 4352 (lane 3), Kp 08 (lane 4), Kp 06 (lane 5), Kp 03 (lane 6)](bjm-42-467-g001){#fig1}

In conclusion, this data suggests that resistance to *K. pneumoniae* clinical isolates is due to the association between extended-spectrum beta-lactamases (ESLBs)-producing with lost outer membrane proteins. Further studies, using techniques of molecular biology will be developed with the intention of confirming production ESBLs.
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